Thus, the present study aimed to evaluate the expression of the circulating tumor markers CK20 and MUC1 in peripheral blood samples from GC patients, who underwent gastrectomy, and to verify the association of their expression levels with clinicopathological characteristics and survival. The gene discussed is MUC1; the disease is gastric cancer.